Skip to main content
Home > About Us > Editorial & Research

Editorial & Research Team

› Senior Editors

Karen Bernstein, Ph.D., Co-Founder, Chairman & Editor-in-Chief
Karen has been writing and publishing on biotechnology since 1987. She holds a Ph.D. in political science from Stanford University and a B.A. in politics and history from Brandeis University, where she served for many years as a member of the Brandeis University Science Advisory Council. She is on the board of trustees of the Keck Graduate Institute of the Applied Life Sciences and is a member of the board of advisors of KGI's School of Pharmacy. In 2005, the annual gathering of biotechnology chief executive officers at The Biotech Meeting in Laguna Niguel, Calif., inducted Karen into their Hall of Fame, citing her lifetime contribution to the biotech community. In 2007, Karen received a Special Recognition award at the American Liver Foundation's Salute to Excellence, honoring individuals who have made an outstanding contribution to biotechnology and medical innovation..
 
Jeff Cranmer, Managing Editor, BioCentury
Jeff serves as Managing Editor of BioCentury. Since joining BioCentury in 2005, Jeff has also been Editor of BioCentury Extra and head of BioCentury's Research Group. Jeff has an A.B. from Princeton University and an M.A. from the Johns Hopkins School of Advanced International Studies.
 
Steve Edelson, Senior Editor
Steve serves as a Senior Editor for BioCentury. He has been a writer and editor for BioCentury since 1998, including as Executive Editor of BioCentury Innovations and Editor of BioCentury Extra and as Senior Writer responsible for financial markets coverage. Steve has an M.S. in biotechnology from Northwestern University, where he also received a B.A. in biochemistry.
 
Simone Fishburn, Ph.D., Editor, BioCentury Innovations

Simone serves as Editor of Biocentury Innovations. Prior to joining BioCentury in 2013, Simone worked as a translational scientist in biotech, including nine years in preclinical drug development at Nektar Therapeutics. Before industry, Simone carried out research at the Weizmann Institute of Science, after completing a post-doc at the University of California, San Francisco (UCSF). Simone also serves as an advisor on the translational SPARK program at Stanford University and the CTSI Catalyst program at UCSF. Simone is also active in programs to advance women's careers, and was president of Women In Bio from 2013-2014. She is a Fulbright scholar, and holds a Ph.D. in molecular pharmacology from the Weizmann, and an M.A. and B.A. in pharmacology from Cambridge University.

 
Erin McCallister, Senior Editor
Erin joined BioCentury in 2008. She previously was a program officer at The Great Lakes Protection Fund and a biologist at Dow AgroSciences LLC. She holds an M.Sc. in environmental science and policy from the University of Chicago and a B.S. in biology from Purdue University.
 
Susan Schaeffer, Editor, BioCentury
Susan serves as Editor of BioCentury. She was previously Senior Editor in charge of Product Discovery & Development coverage from 2010 through 2012. She was Managing Editor of BioCentury and BioCentury Extra from 2004 through 2010. She joined BioCentury in 2003 after 10 years as an editor in the consumer packaged goods sector, including work with international strategy consultants Kurt Salmon Associates.
 
Steve Usdin, Senior Editor, Washington
Steve has been Washington Editor of BioCentury since 1993, and has spent the past 20 years in the nation's capital covering political and policy issues affecting the life sciences sector. He also is BioCentury Senior Editor responsible for coverage of social issues involving biotechnology, as well as the former host of BioCentury This Week, BioCentury's public affairs television program. Steve’s reporting about biotechnology and biomedical policy has been cited in The Economist, The Wall Street Journal, the Washington Post, New Scientist and other publications. In 2012, the FDA Alumni Association named Steve the Harvey W. Wiley Lecturer, making him the first journalist to receive the Wiley Award. His book, “Engineering Communism: How Two Americans Spied for Stalin and Founded the Soviet Silicon Valley,” was published in 2005 by Yale University Press.
 
Walter Yang, Director of Research
Walter, who directs BioCentury's editorial research effort, has been a Staff Writer and Research Analyst since joining the company in 1999. Walter previously worked as a researcher at the Salk Institute for Biological Studies. He holds a B.S. in molecular biology from the University of California, San Diego, and has a master's degree in accounting and finance from the London School of Economics and Political Science.
 

› Associate Editors

Michael J. Haas, Associate Editor
Mike joined BioCentury in 2007 after gaining nearly 14 years of experience as an analytical chemist and mass spectrometry group leader at DuPont, DuPont Merck, DuPont Pharma and Bristol-Myers Squibb. He holds an M.Sc. in chemistry from the University of Toronto and a B.S. in chemistry from the University of Delaware.
 
Stephen Hansen, Associate Editor
Stephen has been a writer and news editor for BioCentury since 2006. He holds B.A.s in biology and history from Bethel University and an M.Phil in history from Oxford University.
 

› Senior Writers

Emily Cukier-Meisner, Senior Writer
Emily joined BioCentury in 2013 after gaining over six years of experience in the analysis and classification of clinical-stage drug products at Brand Institute. Previously, she conducted studies of protein folding at the University of Chicago and University of Cincinnati. She holds a B.S. in chemistry from Harvey Mudd College and an M.S. from the University of Chicago in biochemistry and molecular biology.
 
Stephen F. Parmley, Ph.D., Senior Writer
Stephen joined BioCentury in 2014 after gaining nearly 15 years of experience as a biotech project leader at Maxygen, Perseid Therapeutics, and Astellas Pharma. His past research projects have included pioneering work on phage display, vaccines, and protein drug discovery. Stephen holds a Ph.D. in molecular biology from the University of Missouri-Columbia and a B.S. in cell biology from the University of Kansas.